Kura Oncology, Inc.
KURA
$9.22
-$0.52-5.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 9.46% | -9.29% | -12.09% | -15.14% | -198.84% |
| Total Depreciation and Amortization | -11.91% | 145.73% | -26.79% | -7.05% | 18.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.33% | 9.70% | 101.05% | -14.04% | -9.73% |
| Change in Net Operating Assets | -110.92% | 1,284.31% | -148.71% | 262.35% | -107.10% |
| Cash from Operations | -173.21% | 245.45% | -180.18% | 59.99% | -126.73% |
| Capital Expenditure | 94.49% | 9.58% | -76.06% | -399.32% | 21.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.30% | -164.51% | 59.83% | 159.73% | -6.91% |
| Cash from Investing | 62.49% | -168.74% | 59.42% | 158.12% | -6.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -93.92% | -- | -100.00% | 260.14% | -82.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -93.92% | -- | -100.00% | 260.14% | -82.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -304.45% | 303.42% | -56.52% | 117.71% | -198.98% |